Article Per Year (5 Year)
p-Index From 2019 - 2024
0.444
P-Index
This Author published in this journals
All Journal Health Information : Jurnal Penelitian Jurnal Ners
Kentanto, Given
Unknown Affiliation
Dentistry Health Professions Medicine & Pharmacology Nursing Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Potensi Penggunaan Agen Anti-Fungal Naftifine Sebagai Terapi Inovatif Tinea: Sebuah Tinjauan Literatur Titanic, Pussof Yayazucah; Arliska, Vira Geraldine; Johansen, Johansen; Kentanto, Given; Priyanto, Teguh
Health Information : Jurnal Penelitian Content Digitized
Publisher : Poltekkes Kemenkes Kendari

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

A disease with the first name "Tinea" is aninfection caused by the presence of dermatophyte fungi that can occur invarious locations of the body. Tinea corporis is a superficial fungalskin infection of the body caused by dermatophytes, specifically on thetrunk, neck, arms and legs. Other forms of tinea infection based on itslocation are on the scalp (tinea capitis), face (tinea faciei), hands(tinea manuum), groin (tinea cruris), and feet (tinea pedis). Ingeneral, there are 3 genera that can cause this condition ofdermatophytosis (tinea), namely the genera Trichophyton, Epidermophyton,and Microsporum. Currently, there are various topical anti-fungal agentsfor treating dermatophytosis (tinea). The two main classes thatrepresent the majority of available topical antifungal agents are azolesand allylamines. Overall, the allylamines (naftifine) are superior tothe azoles in activity against dermatophytes, although both areclinically effective. Therefore, in this literature review, we conductedan analysis of the effects of using naftifine in treating various typesof tinea. Study searches were conducted on various databases such asPubmed, ScienceDirect, Directory of Open Access Journals, and theCochrane Library. From the search results obtained a total of 212studies. The studies that met the inclusion and exclusion criteria werethe 3 studies analyzed in this literature review. Administration ofNaftifine showed a higher mycological cure rate, therapeuticeffectiveness, clinical symptoms, and cure rate than the control group.No adverse events were reported with any type of naftifine in allinclusion studies. Administration of naftifine is a therapy with sideeffects in treating various types of tinea(dermatophytosis).
Managing Refractory Myasthenia Gravis In-Depth Multidisciplinary Exploration: Case Report Kentanto, Given; Sunaryo, Sunaryo
Jurnal Ners Vol. 8 No. 2 (2024): OKTOBER 2024
Publisher : Universitas Pahlawan Tuanku Tambusai

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31004/jn.v8i2.23387

Abstract

Our case of a 38-year-old female patient with refractory Myasthenia Gravis (MG) is presented, emphasizing the intricate and evolving nature of the disease. The patient exhibits predominant cranial and upper respiratory muscle involvement, characteristic of ocular MG, accompanied by diurnal symptom variation. The case underscores the imperative of individualized therapeutic strategies aimed at achieving disease stability and enhancing the patient's quality of life. Additionally, it highlights the pressing need for ongoing research and advancements in MG management, emphasizing tailored care and a multidisciplinary approach to address refractory cases effectively. This clinical journey exemplifies the complexities and opportunities inherent in the management of refractory MG within the context of contemporary medical practice.
Co-Authors Arliska, Vira Geraldine Johansen Johansen Priyanto, Teguh Sunaryo Sunaryo Titanic, Pussof Yayazucah